DeCODE genetics, an Amgen-owned company, claimed it has identified a new genetic variant involving the ASGR1 gene, a finding that can reduce heart disease risk by 35 percent.
DeCODE genetics, an Amgen-owned company, claimed it has identified a new genetic variant involving the ASGR1 gene, a finding that can reduce heart disease risk by 35 percent.